1. Home
  2. STELLA PHARMA NEWS
  3. 2023年12月
STELLA PHARMA NEWS
2023年12月
December 25th, 2023

Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma

Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……

READ MORE

December 13th, 2023

Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—

Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……

READ MORE

December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

READ MORE